Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1961 1
1966 1
1972 1
1973 1
1974 1
1975 4
1976 9
1977 12
1978 7
1979 20
1980 41
1981 66
1982 96
1983 150
1984 197
1985 278
1986 366
1987 451
1988 517
1989 684
1990 702
1991 891
1992 780
1993 756
1994 666
1995 623
1996 638
1997 546
1998 476
1999 457
2000 409
2001 326
2002 371
2003 318
2004 320
2005 358
2006 306
2007 312
2008 304
2009 261
2010 269
2011 258
2012 263
2013 290
2014 245
2015 235
2016 202
2017 225
2018 217
2019 184
2020 223
2021 235
2022 216
Text availability
Article attribute
Article type
Publication date

Search Results

15,159 results
Results by year
Filters applied: . Clear all
Page 1
Platelet-activating factor.
Prescott SM, Zimmerman GA, McIntyre TM. Prescott SM, et al. J Biol Chem. 1990 Oct 15;265(29):17381-4. J Biol Chem. 1990. PMID: 2170377 Free article. Review. No abstract available.
Platelet-activating factor antagonists.
Saunders RN, Handley DA. Saunders RN, et al. Annu Rev Pharmacol Toxicol. 1987;27:237-55. doi: 10.1146/annurev.pa.27.040187.001321. Annu Rev Pharmacol Toxicol. 1987. PMID: 3555317 Review.
Over the past decade platelet-activating factor has achieved the status of an important inflammatory mediator. ...
Over the past decade platelet-activating factor has achieved the status of an important inflammatory mediator. ...
Platelet-activating factor.
Owen JS, Thomas MJ, Wykle RL. Owen JS, et al. Methods Enzymol. 2007;434:105-16. doi: 10.1016/S0076-6879(07)34006-8. Methods Enzymol. 2007. PMID: 17954244
Platelet-activating factor (PAF) is a potent mediator that occurs at very low concentrations in cells and tissues. ...
Platelet-activating factor (PAF) is a potent mediator that occurs at very low concentrations in cells and tissues. ...
Platelet-activating factor (PAF)-antagonists of natural origin.
Singh P, Singh IN, Mondal SC, Singh L, Garg VK. Singh P, et al. Fitoterapia. 2013 Jan;84:180-201. doi: 10.1016/j.fitote.2012.11.002. Epub 2012 Nov 16. Fitoterapia. 2013. PMID: 23160091 Review.
Presently herbal medicines are being used by about 80% of the world population for primary health care as they stood the test of time for their safety, efficacy, cultural acceptability and lesser side effects. The discovery of platelet activating factor antag …
Presently herbal medicines are being used by about 80% of the world population for primary health care as they stood the test of time for th …
Platelet activating factor antagonists.
Summers JB, Albert DH. Summers JB, et al. Adv Pharmacol. 1995;32:67-168. doi: 10.1016/s1054-3589(08)61012-1. Adv Pharmacol. 1995. PMID: 7748804 Review. No abstract available.
Platelet-activating factor.
Wykle RL, O'Flaherty JT, Thomas MJ. Wykle RL, et al. Methods Enzymol. 1988;163:44-54. doi: 10.1016/0076-6879(88)63006-0. Methods Enzymol. 1988. PMID: 3237085 No abstract available.
Platelet-activating factor in the CNS.
Maclennan KM, Smith PF, Darlington CL. Maclennan KM, et al. Prog Neurobiol. 1996 Dec;50(5-6):585-96. doi: 10.1016/s0301-0082(96)00047-0. Prog Neurobiol. 1996. PMID: 9015828 Review.
Platelet-activating factor (PAF) is a phospholipid synthesized in a variety of cells throughout the body. Platelet-activating factor has been identified in the CNS and has a number of diverse physiological and pathological functions. ...
Platelet-activating factor (PAF) is a phospholipid synthesized in a variety of cells throughout the body. Platelet
Platelet-activating factor in stroke and brain injury.
Lindsberg PJ, Hallenbeck JM, Feuerstein G. Lindsberg PJ, et al. Ann Neurol. 1991 Aug;30(2):117-29. doi: 10.1002/ana.410300202. Ann Neurol. 1991. PMID: 1897906 Review.
Platelet-activating factor is released together with eicosanoids such as thromboxane A2, prostacyclin, and leukotrienes. ...We discuss the mechanisms and significance of platelet-activating factor-mediated effects and propose directions f
Platelet-activating factor is released together with eicosanoids such as thromboxane A2, prostacyclin, and leukotrienes
Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling.
Marathe GK, Chaithra VH, Ke LY, Chen CH. Marathe GK, et al. Prostaglandins Other Lipid Mediat. 2020 Dec;151:106478. doi: 10.1016/j.prostaglandins.2020.106478. Epub 2020 Jul 22. Prostaglandins Other Lipid Mediat. 2020. PMID: 32711129 Review.
Platelet-activating factor (PAF), a bioactive ether phospholipid with significant pro-inflammatory properties, was identified almost half a century ago. ...
Platelet-activating factor (PAF), a bioactive ether phospholipid with significant pro-inflammatory properties, was iden
Embryo-derived platelet activating factor.
O'Neill C. O'Neill C. Reprod Fertil Dev. 1992;4(3):283-8. doi: 10.1071/rd9920283. Reprod Fertil Dev. 1992. PMID: 1438959 Review.
Platelet-activating factor (PAF) is secreted by the preimplantation embryo of a number of species. ...
Platelet-activating factor (PAF) is secreted by the preimplantation embryo of a number of species. ...
15,159 results
You have reached the last available page of results. Please see the User Guide for more information.